PMID- 32922056 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220416 IS - 1178-7007 (Print) IS - 1178-7007 (Electronic) IS - 1178-7007 (Linking) VI - 13 DP - 2020 TI - Delays in Insulin Initiation among Patients with Type 2 Diabetes Mellitus in Southeast China: A Retrospective, Real-World Study. PG - 3059-3068 LID - 10.2147/DMSO.S256381 [doi] AB - PURPOSE: To describe the extent of delays in insulin initiation, analyze its impact on glycemic control, and explore factors influencing delayed insulin initiation among Chinese type 2 diabetes mellitus (T2DM) patients. METHODS: A real-world, retrospective cohort study with regional electronic health records from Fuzhou, southeast China was conducted among T2DM patients. Adult patients uncontrolled with oral antidiabetic drugs (OADs; HbA(1c) >/=7%) and initiated on insulin treatment were included. Time to insulin initiation was described. After propensity-score matching, Wilcoxon rank-sum test and chi-square test were used to compare follow-up HbA(1c) (first HbA(1c) 3 months after insulin initiation) between timely (initiated insulin within 6 months after OAD failure) and delayed (initiated after 6 months) insulin-initiation groups. Sensitivity analysis was also performed by linear and logistic regression. Factors associated with delayed insulin initiation were explored using logistic regression. RESULTS: A total of 940 patients were included, with mean+/-SD age 66.3+/-11.9 years. In sum, 328 had HbA(1c) recorded 3 months after insulin initiation. After propensity-score matching (1:1 matching), 184 patients were included for further analysis. Median follow-up HbA(1c) was lower in the timely-initiation group than the delayed-initiation group (7.25% vs 8.25%, P=0.009). Patients in the timely initiation group also had higher odds of achieving HbA(1c) <7% (OR=3.15, P=0.001). Results were confirmed by logistic regression. Hypertension, coronary artery disease, baseline HbA(1c), and hospital level at insulin initiation were associated with delays in insulin initiation. CONCLUSION: Timely insulin initiation after OAD failure is associated with better glycemic control. CI - (c) 2020 Chen et al. FAU - Chen, Pin AU - Chen P AD - Department of Endocrinology, 900 Hospital of the Joint Logistics Team, Fuzhou Clinical Medical College of Fujian Medical University, Fuzhou, People's Republic of China. FAU - Ma, Xiao AU - Ma X AD - Lilly Suzhou Pharmaceutical, Shanghai, People's Republic of China. FAU - Chen, Hong AU - Chen H AD - Lilly Suzhou Pharmaceutical, Shanghai, People's Republic of China. FAU - Wang, Ke AU - Wang K AD - Lilly Suzhou Pharmaceutical, Shanghai, People's Republic of China. FAU - Zhou, Li AU - Zhou L AUID- ORCID: 0000-0003-3750-3309 AD - Lilly Suzhou Pharmaceutical, Shanghai, People's Republic of China. LA - eng PT - Journal Article DEP - 20200825 PL - New Zealand TA - Diabetes Metab Syndr Obes JT - Diabetes, metabolic syndrome and obesity : targets and therapy JID - 101515585 PMC - PMC7457728 OTO - NOTNLM OT - HbA1c OT - delayed insulin initiation OT - glycemic control OT - therapeutic inertia OT - type 2 diabetes mellitus COIS- Li Zhou, Xiao Ma, and Hong Chen are employees of Lilly. Ke Wang was an employee of Lilly at the time of manuscript preparation. Pin Chen has nothing to disclose. Li Zhou reports personal fees from Eli Lilly and Company during the conduct of the study. The authors report no other potential conflicts of interest for this work. EDAT- 2020/09/15 06:00 MHDA- 2020/09/15 06:01 PMCR- 2020/08/25 CRDT- 2020/09/14 05:49 PHST- 2020/04/01 00:00 [received] PHST- 2020/07/10 00:00 [accepted] PHST- 2020/09/14 05:49 [entrez] PHST- 2020/09/15 06:00 [pubmed] PHST- 2020/09/15 06:01 [medline] PHST- 2020/08/25 00:00 [pmc-release] AID - 256381 [pii] AID - 10.2147/DMSO.S256381 [doi] PST - epublish SO - Diabetes Metab Syndr Obes. 2020 Aug 25;13:3059-3068. doi: 10.2147/DMSO.S256381. eCollection 2020.